Related Experiment Videos
Abasic sites induce triplet-repeat expansion during DNA replication in vitro
1Lineberger Comprehensive Cancer Center and Department of Pathology, University of North Carolina Medical School, Chapel Hill, North Carolina 27599-7295, USA.
The Journal of Biological Chemistry
|September 3, 1999
Summary
DNA damage, specifically abasic sites, significantly induces triplet-repeat expansion (TRE) during DNA replication. This finding suggests DNA damage plays a key role in generating TRE in vivo, contributing to genetic diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Triplet-repeat expansion (TRE) is implicated in neurological and neuromuscular diseases like Fragile X syndrome.
- DNA slippage during replication is a known cause of TRE, but its origins are unclear.
- Abasic sites are common DNA lesions that can stall replication forks.
Purpose of the Study:
- To investigate the role of abasic sites in inducing triplet-repeat expansion (TRE) during DNA replication.
- To determine how the location and sequence context of abasic sites affect TRE.
- To elucidate the mechanism by which DNA damage contributes to genetic instability.
Main Methods:
- In vitro DNA replication assays using Escherichia coli Klenow polymerase I.
- Synthesis of template DNA containing an abasic site analog within a triplet-repeat tract.
- Sequencing of expanded DNA tracts to confirm repeat additions.
Main Results:
- A single abasic site analog in the template strand induced significant TRE.
- TRE induction decreased as the abasic site moved towards the middle of the repeat tract.
- TRE was sequence-dependent, with AAT/ATT repeats showing higher expansion rates than CAG/CTG repeats.
- Expansions required primer-template complementarity and resulted in multiple repeat additions.
Conclusions:
- Abasic sites are potent inducers of TRE during DNA replication.
- The position and sequence context of DNA damage influence TRE frequency.
- DNA damage is a significant factor in the generation of TRE in vivo, potentially contributing to disease pathogenesis.